shares to private placement, that is not used for the purpose specified in the notice of the shareholders’. SEC Act S.300 in conjunction with 35 Settlement Committee Meeting No. 4/2026 Settlement
of new shares to private placement, that is not used for the purpose specified in the notice of the shareholders’. SEC Act S.300 in conjunction with 35 Settlement Committee Meeting No. 4/2026
private placement, that is not used for the purpose specified in the notice of the shareholders’. SEC Act S.300 in conjunction with 35 Settlement Committee Meeting No. 4/2026 Settlement Committee
offering of new shares to private placement, that is not used for the purpose specified in the notice of the shareholders’. SEC Act S.300 in conjunction with 35 Settlement Committee Meeting No. 4/2026
private placement, that is not used for the purpose specified in the notice of the shareholders’. SEC Act S.300 in conjunction with 35 Settlement Committee Meeting No. 4/2026 Settlement Committee Order
Acquisition of Assets of DOD Biotech Public Company Limited regarding the Acquisition of Land and Establishment of Subsidiary, which is Class 2 Transaction (Schedule 1) DOD Biotech Public Company Limited ( the
approve the entry into the transaction; (d) To deliver the notice of the shareholders’ meeting to the shareholders not less than 14 days in advance, whereby such notice shall contain minimum information as
1 8 July 2019 Subject: The entering into the transaction of requesting to return a license to use the spectrum and operate a television business of the subsidiary of the Company (Spring 26 Company